A new rho(D) map to diffuse gastric cancer

Dorothy Benton, Jonathan Chernoff

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Diffuse gastric cancer (DGC) is characterized by frequent missense mutations in the small GTPase RHOA, but the effects of this mutation on enzyme activity and signaling have been widely debated. In this issue, Zhang and colleagues show that the most common RHOA mutation in DGC, encoding RHOAY42C, represents a gain of function; that a mouse model incorporating this mutation in association with loss of the E-cadherin gene CDH1 recapitulates many aspects of DGC; and that rationally designed therapeutics based on our understanding of RHOA signaling are promising agents for treating DGC.

Original languageEnglish
Pages (from-to)182-184
Number of pages3
JournalCancer Discovery
Volume10
Issue number2
DOIs
StatePublished - Feb 2020

Fingerprint

Dive into the research topics of 'A new rho(D) map to diffuse gastric cancer'. Together they form a unique fingerprint.

Cite this